Staff Reports
A newly released whistleblower complaint now claims DEA agents were told to watch a fentanyl shipment move from Arizona into New Mexico and not to seize it or make arrests. The complaint joins earlier disclosures from other DEA insiders and has pushed the Justice Department’s watchdog, the DOJ Office of Inspector General, into an expanding review. If true, the decision to “monitor, not arrest” reads like a political experiment with other people’s lives as the lab rats.
What the new complaint says
Key details from the allegation
The complaint, circulated by the whistleblower’s attorney, describes a November 2022 courier tracked into New Mexico whom agents were ordered to follow instead of stop. It says that same courier allegedly made several more deliveries carrying tens of thousands of counterfeit fentanyl pills and large amounts of meth. When the suspect was finally arrested months later, agents reportedly found multiple kilograms of fentanyl and meth. Another agent allegedly shrugged in training and said, “We walk fentanyl,” a line whistleblowers say prosecutors knew about. The filing also accuses supervisors of threatening and “icing” agents who complained, and it echoes earlier complaints from DEA agent David Howell and contractor Kevin Small.
Why the complaint matters
Fentanyl is not ordinary contraband. A few milligrams can be deadly, so letting hundreds of thousands of pills slip through on the theory of building a bigger case is not just risky — it is morally questionable. Public reporting has already documented a June 2023 transaction of roughly 74,000 counterfeit pills that agents tracked and did not seize. National overdose numbers remain painfully high, with synthetic opioids the leading cause. Critics say law enforcement tactics that might work for slower, bulkier drugs should not be applied to an opioid that can kill with a speck-sized dose.
Who’s in the hot seat — and what they say
The DEA has asked the DOJ watchdog to investigate and says its leaders want a careful, fact-based review; the agency denies knowingly permitting fentanyl to reach communities. U.S. Attorney Alex Uballez, who supervised some of the work in New Mexico, publicly defended long investigations with the line that “the bigger fish are worth catching.” That argument will not comfort grieving families. New Mexico officials and whistleblower attorneys have pressed for more transparency and for protections against retaliation. If supervisors did order agents to sit back while poison moved into neighborhoods, someone needs to answer for that choice — not just offer well-crafted PR.
What must happen next
The OIG should get the complaint, the intake records, and any written guidance that directed agents on when to seize fentanyl versus when to surveil. Congressional oversight and local prosecutors should demand the same documents. Whistleblowers deserve protection, not punishment. And the public deserves plain answers: who signed off on these tactics, why they thought this gamble was acceptable, and what steps will stop it from happening again. Let’s not pretend this is merely a law-enforcement debate; it’s about whether agencies put case-building above saving lives. That question deserves a full, public accounting — and quick action if the allegations prove true.
